儿童、青少年及年轻成人甲状腺乳头状癌放射性碘难治性肺转移
本研究纳入65例年龄≤20岁、确诊肺转移的甲状腺乳头状癌患者,比较放射性碘亲和(RAIA)与放射性碘难治(RAIR)组的临床病理特征。RAIR组占30.8%(20/65),年龄<15岁患者更易发生RAIR(HR 3.500,95%CI 1.134-10.803,P=.023)。RAIR是进展性疾病的独立预测因子(HR 10.008,95%CI 2.427-41.268,P=.001),RAIR组无进展生存率和疾病特异性生存率均低于RAIA组(P<.001和P=.039)。
要点
- 年龄≤20岁甲状腺乳头状癌肺转移患者中,RAIR占30.8%(20/65)。
- 年龄<15岁患者发生RAIR的风险是15-20岁患者的3.500倍(HR 3.500,95%CI 1.134-10.803,P=.023)。
- RAIR是进展性疾病的独立预测因子(HR 10.008,95%CI 2.427-41.268,P=.001)。
核心结论
- RAIR疾病发生于约三分之一的儿童、青少年及年轻成人甲状腺乳头状癌肺转移患者。
- 年龄<15岁患者更易发生RAIR状态,并导致不良的无进展生存率和疾病特异性生存率。
研究设计与样本
- 纳入65例年龄≤20岁、确诊肺转移的甲状腺乳头状癌患者,比较RAIA组与RAIR组的临床病理特征。
- 采用单因素和多因素回归分析识别RAIR状态和进展性疾病的危险因素。
- 对17例患者进行了基因变异检测。
主要发现
- RAIR组20例,占全部患者的30.8%(20/65)。
- 年龄<15岁与15-20岁患者在病理特征上无显著差异,但年轻患者更易发生RAIR疾病(HR 3.500,95%CI 1.134-10.803,P=.023)。
- RET融合是儿童、青少年及年轻成人甲状腺乳头状癌中最常见的基因变异,但未发现其与RAIR疾病的关联(P=.210)。
- RAIR疾病是进展性疾病的独立预测因子(HR 10.008,95%CI 2.427-41.268,P=.001)。
- Kaplan-Meier曲线显示RAIR组无进展生存率和疾病特异性生存率均低于RAIA组(P<.001和P=.039);在年龄<15岁患者中,RAIR疾病是不良无进展生存的危险因素(P<.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Few studies have explored radioactive iodine-refractory (RAIR) disease in children, adolescents, and young adults with papillary thyroid cancer (CAYA-PTC). OBJECTIVE: This study systematically investigated the clinicopathologic characteristics and prognosis of CAYA-PTC with RAIR disease. METHODS: Sixty-five patients with PTC aged ≤20 years were enrolled in this study, and all patients were confirmed to have pulmonary metastases. Clinicopathologic profiles were compared between the radioactive iodine-avid (RAIA) and RAIR groups. Univariate and multivariate regression analyses were performed to identify risk factors for RAIR status and progressive disease (PD). Gene alterations were detected in 17 patients. RESULTS: Overall, 20 patients were included in the RAIR group, accounting for 30.8% (20/65) of all patients. No significant difference in pathologic characteristics was observed between patients aged <15 years and patients aged 15-20 years, but younger patients were more likely to develop RAIR disease (hazard ratio [HR] 3.500, 95% CI 1.134-10.803, P = .023). RET fusions were the most common genetic alterations in CAYA-PTC, but an association with RAIR disease was not detected (P = .210). RAIR disease (HR 10.008, 95% CI 2.427-41.268, P = .001) was identified as an independent predictor of PD. The Kaplan-Meier curve revealed a lower progression-free survival (PFS) and disease-specific survival (DSS) rate in the RAIR group than in the RAIA group (P < .001 and P = .039). Likewise, RAIR disease was a risk factor for unfavorable PFS in patients aged <15 years (P < .001). CONCLUSION: RAIR disease occurs in one-third of CAYA-PTC with pulmonary metastases. Younger patients (aged < 15 years) are more susceptible to RAIR status, which leads to unfavorable PFS and DSS.
引用
- Tian T, Huang S, Dai H, et al. Radioactive Iodine-Refractory Pulmonary Metastases of Papillary Thyroid Cancer in Children, Adolescents, and Young Adults. J Clin Endocrinol Metab. 2023. PMID: 36226635. doi:10.1210/clinem/dgac600
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。